Occurs less frequently in young patients with acute myelogenous leukemia.
Older patients with acute myelogenous leukemia have a high rate of MDR1, 71%,.
Increased expression in AML in patients with favorable or intermediate cytogenetics have a decreased complete remission rates and, in some studies, poorer survival.